Literature DB >> 10553883

Ceramide-induced vasorelaxation: An inhibitory action on protein kinase C.

D G Johns1, J S Jin, D W Wilde, R C Webb.   

Abstract

Experiments were designed to examine the role of sphingosine, PP2A phosphatases, and protein kinase C (PKC) inhibition in mediating the vasodilatory effects of ceramide in rat thoracic aorta. Sphingosine did not cause vasorelaxation, and oleoylethanol-amine, a ceramidase inhibitor, did not affect sphingomyelinase-induced relaxation. Okadaic acid potentiated the relaxation response to ceramide. These observations rule out involvement of sphingosine and PP2A phosphatases in mediating ceramide-induced relaxation. Sphingomyelinase attenuated contractile and single-cell intracellular calcium responses to phorbol ester. Chelerythrine incubation potentiated the relaxation response to ceramide. These observations support a role for PKC inhibition in mediating the vasodilatory effects of ceramide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553883     DOI: 10.1016/s0306-3623(99)00038-5

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  High activity of acid sphingomyelinase in major depression.

Authors:  J Kornhuber; A Medlin; S Bleich; V Jendrossek; A W Henkel; J Wiltfang; E Gulbins
Journal:  J Neural Transm (Vienna)       Date:  2005-11       Impact factor: 3.575

2.  Gemcitabine kills proliferating endothelial cells exclusively via acid sphingomyelinase activation.

Authors:  Albert J van Hell; Adriana Haimovitz-Friedman; Zvi Fuks; William D Tap; Richard Kolesnick
Journal:  Cell Signal       Date:  2017-02-24       Impact factor: 4.315

3.  Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse.

Authors:  Fiona H Greig; Katrin Nather; Margaret D Ballantyne; Zeshan H Kazi; Husam Alganga; Marie-Ann Ewart; Karolina E Zaborska; Bracy Fertig; Nigel J Pyne; Susan Pyne; Simon Kennedy
Journal:  Eur J Pharmacol       Date:  2018-10-23       Impact factor: 4.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.